richard
feynman
describ
process
allow
one
individu
manipul
atom
molecul
throughout
high
precis
instrument
system
could
appli
design
build
system
nanoscal
level
atom
atom
applic
mani
area
wide
interest
health
industri
pharmaci
etc
seem
unlimit
engin
eric
drexler
inspir
feynman
speech
publish
articl
entitl
molecular
engin
approach
develop
gener
capabl
molecular
manipul
describ
detail
feynman
previous
describ
term
nanotechnolog
first
appli
drexler
use
area
expertis
sinc
nanotechnolog
refer
area
knowledg
design
produc
structur
devic
system
manipul
atom
molecul
nanoscal
level
nanoparticl
microscop
particl
smaller
nanomet
due
small
size
nanoparticl
unusu
properti
make
use
nanomedicin
advantag
nowaday
nanoparticl
obtain
transit
metal
silicon
carbon
metal
oxid
nanobiotechnolog
area
nanotechnolog
focus
biolog
field
nanoparticl
util
biolog
group
three
categori
organ
inorgan
mix
organicinorgan
recent
year
mani
nanoparticl
develop
divers
applic
medicin
includ
infecti
diseas
develop
nanoparticl
area
benefici
due
select
antimicrobi
effect
low
toxic
host
abil
place
action
specif
target
shuttl
system
commonli
use
deliveri
stabil
bioactiv
drug
antimicrobi
molecul
ensur
specif
also
control
releas
coat
medic
devic
great
advantag
infecti
diseas
field
eg
nanomodifi
surfac
devic
prove
effici
reduc
microbi
attach
biofilm
format
use
nanomateri
biosensor
current
vast
impact
fast
develop
usag
smart
nanobiomateri
biosensor
accur
offer
cost
effect
approach
detect
pathogen
infecti
agent
natur
environ
food
also
clinic
specimen
nanondiagnost
first
introduc
mirkin
et
al
author
publish
use
gold
au
nanoparticl
allow
anthrax
detect
aim
review
highlight
discuss
recent
progress
applic
nanotechnolog
medic
field
nanomedicin
focus
prevent
diagnosi
treatment
infecti
diseas
tradit
vaccin
develop
use
live
attenu
organ
cellular
vaccin
inactiv
toxin
protein
acellular
vaccin
recent
develop
synthet
peptidebas
vaccin
shown
mani
advantag
compar
tradit
vaccin
better
safeti
andor
conserv
howev
peptidebas
vaccin
gener
weaker
immun
respons
inclus
adjuv
andor
use
vaccin
deliveri
system
highli
need
antibacteri
vaccin
cellular
acellular
still
consid
cost
effect
intervent
bacteri
infect
implement
vaccin
schedul
decreas
worldwid
morbid
mortal
caus
infecti
diseas
diphtheria
pneumococc
pertussi
diseas
howev
treatment
prevent
common
bacteri
infect
includ
limit
staphylococcu
aureu
helicobact
pylori
shigella
spp
escherichia
coli
still
possibl
nanoparticl
sever
applic
nanobiomedicin
especi
field
vaccin
product
appli
effici
deliveri
system
particular
natur
increas
crosspresent
peptid
also
play
import
role
activ
antigen
present
cell
apc
main
applic
synthet
nanoparticl
immun
engin
reli
modul
apc
encapsul
releas
molecul
promot
dendrit
cell
activ
trigger
particlespecif
immun
recognit
thu
antigen
process
nanoparticl
act
coadjuv
stimul
proper
pro
antiimmun
pathway
immunostimul
achiev
encapsul
variou
compound
andor
accord
structur
composit
addit
hypersensit
produc
nanoparticl
use
amelior
slow
rate
infus
deliveri
nanovaccin
system
modul
shape
size
patient
premed
nanomateri
may
intrins
immunomodulatori
function
act
adjuv
immun
potenti
accord
nanomateri
composit
vaccineassoci
nanoparticl
could
classifi
differ
type
tabl
polym
divid
turn
nanoparticl
contain
synthet
polym
poli
llacticcoglycol
acid
plga
polyethylen
glycol
pge
polyest
biobead
natur
polym
base
polysaccharid
algin
inulin
chitosan
synthet
natur
polym
use
synthes
hydrogel
nanoparticl
favor
properti
includ
limit
flexibl
mesh
size
larg
surfac
area
multival
conjug
high
water
content
high
antigen
load
capac
ii
liposom
biodegrad
nontox
phospholipid
encapsul
antigen
incorpor
viral
envelop
glycoprotein
form
virosom
combin
modifi
cation
liposom
cation
polym
protamin
condens
dna
call
liposomepolycationdna
nanoparticl
lpd
commonli
use
adjuv
deliveri
system
dna
vaccin
studi
iii
nanos
emuls
nanoparticl
exist
oilinwat
waterinoil
form
emuls
carri
antigen
insid
core
increas
effici
vaccin
deliveri
also
simpli
mix
antigen
iv
inorgan
nanoparticl
nonbiodegrad
rigid
structur
control
synthesi
silicabas
nanoparticl
sinp
offer
advantag
biocompat
excel
properti
nanocarri
sinp
particl
mesopor
silica
nanoparticl
msn
could
potenti
becom
higheffici
controlledreleas
nanocarri
futur
vaccin
formul
v
immunostimul
complex
iscom
compos
supramolecular
structur
adjuv
quil
immun
peptid
allow
select
incorpor
viral
envelop
protein
hydrophob
interact
vi
viruslik
particl
vlp
optim
interact
immun
system
avoid
infecti
compon
induc
potent
immun
respons
even
absenc
adjuv
vlp
base
vaccin
first
nanoparticl
class
reach
market
found
exampl
follow
hbv
vii
selfassembl
system
emerg
consequ
attempt
drive
higher
level
protein
consequ
better
immunolog
properti
varieti
natur
protein
selfassembl
nanoparticl
confer
highli
symmetr
stabl
organ
structur
emerg
infect
togeth
fast
evolut
drugresist
bacteria
superbug
trigger
increas
ineffect
actual
therapi
use
treat
infecti
diseas
clinic
microbiolog
laboratori
still
use
convent
phenotyp
method
identif
bacteria
novel
mechan
resist
nowaday
laboratori
support
molecular
biolog
techniqu
base
rrna
sequenc
also
variou
advanc
physicochem
analysi
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
ms
becom
reliabl
method
microbi
identif
sever
hospit
due
speed
accuraci
cost
effect
design
optim
diagnosi
method
paramet
consid
would
costeffect
portabl
point
sourcedetect
system
would
also
highli
reliabl
sensit
accur
desir
method
also
abl
detect
multipl
pathogen
one
singl
run
number
nanotechnologybas
materi
studi
purpos
control
prevent
infecti
diseas
physic
chemic
properti
nanoparticl
allow
accur
rapid
sensit
costeffici
diagnost
antibodybas
diagnos
util
fluoresc
silica
nanoparticl
fsnp
develop
order
detect
mycobacterium
tuberculosi
complex
mtb
within
h
incorpor
europium
eu
iii
polymer
nanoparticl
success
detect
anthrax
antibodi
use
fluoresc
enzym
link
immunosorb
assay
elisa
combin
posit
dielectrophoresi
aptamerfsnp
label
develop
rapid
sensit
method
detect
aureu
wang
kang
develop
recent
method
detect
salmonella
typhimurium
base
singlestrand
dna
aptam
along
silica
fluoresc
nanoparticl
liposom
recogn
target
toxin
therefor
use
toxin
detect
liposom
label
fluoresc
marker
rhodamin
dye
incorpor
sandwich
fluoroimmunoassay
antibodyco
microtit
plate
order
detect
toxin
ahnyoon
et
al
use
method
detect
cholera
toxin
within
limit
detect
fgml
min
similar
assay
develop
detect
botulinum
toxin
bt
nitrocellulos
membran
strip
use
trisialogangliosid
receptor
bt
quantum
dot
qd
special
nanocrystallin
semiconductor
compos
materi
zn
znse
cd
cdse
cdte
inp
among
other
qd
show
strong
resist
photobleach
chemic
degrad
well
signific
photost
high
quantum
yield
characterist
make
suitabl
sensit
imag
acquisit
signal
amplif
real
time
applic
qd
nanobiomedicin
divers
vari
fluoresc
probe
biosensor
therapeut
agent
numer
method
develop
creat
hydrophil
qd
among
qd
bioapplic
import
highlight
multiplex
detect
analyt
base
singl
molecul
detect
qdbase
nanosensor
exampl
highli
sensit
extrem
low
costpersampl
techniqu
ensur
short
analysi
time
potenti
appli
rapid
detect
viral
bacteri
protein
enhanc
sensit
specif
convent
organ
fluorophor
zhang
hu
develop
multiplex
assay
detect
singleqdbas
nanosensor
show
extrem
low
sampl
consumpt
high
sensit
short
analysi
time
result
shown
mani
advantag
method
appli
rapid
pointofcar
test
gene
express
studi
highthroughput
screen
clinic
diagnost
six
year
later
zhang
et
al
design
effici
immunosensorbas
techniqu
screen
isol
salmonella
sp
detect
limit
cellml
aforement
fluoresc
nanobioprob
made
special
design
cellulosebas
swab
could
appli
larg
number
sampl
relat
public
health
surveil
visual
detect
directli
isol
pathogen
situ
klostranec
et
al
report
use
qd
microfluid
obtent
bioimag
signal
improv
high
sensit
use
diagnosi
qdantibodi
conjug
also
success
use
fluoroimmunoassay
detect
staphylococc
enterotoxin
b
syncyti
respiratori
viru
hepatoviru
hvb
hcv
hiv
virus
ebrahim
et
al
abl
synthes
cdteqd
conjug
concanavalin
detect
lipopolysaccharid
lp
produc
serratia
marcescen
detect
rang
coloni
form
unitsml
cfuml
ph
detect
system
base
nobl
metal
nanoparticl
tabl
particularli
au
ag
wide
studi
due
uniqu
optic
physicochem
properti
known
surfac
plasmon
reson
spr
nanos
scale
opticalphysicochem
properti
use
select
specif
identif
dnarna
sequenc
protein
small
analyt
associ
presenc
infect
variou
pathogen
detect
reli
colorimetr
assay
fluoresc
mass
spectrometri
electrochem
scatter
approach
duan
et
al
report
usag
immunegold
silver
stain
aunanoparticl
sensit
method
detect
singl
molecul
applic
detect
hcv
hbv
magnet
nanoparticl
mnp
nanoscal
size
mimic
size
molecul
natur
harbor
favor
characterist
use
nanobiomedicin
imag
therapi
surfac
modif
mnp
recognit
moieti
instanc
antibodi
antibiot
carbohydr
enabl
use
bacteri
detect
recognit
moieti
help
detect
bacteria
select
low
concentr
superparamagnet
properti
provid
mnp
promis
sophist
platform
vivo
detect
techniqu
potenti
make
microbiolog
diagnost
becom
much
easier
worthi
tabl
mnp
classifi
metal
alloy
oxid
gener
base
element
fe
co
ni
mn
among
other
iron
oxid
nanoparticl
ionp
studi
compos
magnetit
maghemit
nanocrystallit
ionpbiosensor
develop
detect
adenovirus
enabl
detect
five
viral
particl
serum
sampl
without
previou
pcr
amplif
step
use
ionp
function
igg
vancomycin
allow
push
limit
detect
cfuml
bacteri
cell
use
nanomaldi
platform
nanodiagnost
system
allow
microbiologist
perform
molecular
test
faster
higher
sensit
method
also
increas
flexibl
reduc
cost
howev
major
new
nanoplatform
still
need
evalu
valid
clinic
sampl
fulli
translat
clinic
diagnosi
drug
resist
great
concern
public
health
use
high
dose
antibiot
treatment
often
gener
high
rate
toxic
develop
new
resist
addit
cost
treatment
increas
major
number
treatment
failur
high
spectrum
therapi
associ
increas
number
hospit
day
due
lack
new
altern
treatment
infecti
diseas
sever
class
antimicrobi
nanoparticl
nanocarri
antibiot
deliveri
studi
well
effect
treatment
infecti
diseas
includ
antibiot
resist
bacteria
nanoparticl
provid
versatil
platform
design
materi
antimicrobi
properti
uniqu
nanoscal
well
physic
chemic
properti
provid
multipl
attribut
facilit
develop
uniqu
antimicrobi
strategi
henc
emerg
weapon
antimicrobi
arsen
nanoantimicrobi
materi
synthes
varieti
differ
method
influenc
subsequ
antimicrobi
effect
could
divid
inorgan
organ
hybrid
nanoparticl
advantag
inorgan
nanomateri
ag
au
alon
combin
variou
organ
polym
figur
antimicrobi
mechan
action
nanoparticl
fulli
known
nevertheless
antimicrobi
action
includ
destruct
cell
membran
blockag
enzym
pathway
alter
microbi
cell
wall
nucleic
materi
pathway
applic
nanoparticl
therapeut
agent
includ
wide
rang
action
vari
broad
spectrum
antimicrobi
agent
steril
wound
heal
agent
sustain
inhibitor
intracellular
pathogen
test
nanoparticl
highli
effici
staphylococcu
aureu
escherichia
coli
accord
properti
even
use
treat
tuberculosi
tb
figur
antibacteri
activ
agnanoparticl
well
establish
although
face
certain
shortcom
due
toxic
mammalian
cell
limit
penetr
biofilm
matric
recent
studi
focus
counter
issu
exampl
develop
ag
ringcoat
superparamagnet
ionp
spion
ligand
gap
demonstr
high
antimicrobi
activ
remark
compat
healthi
host
cell
exhibit
enhanc
activ
biofilm
infect
due
deeper
penetr
extern
magnet
field
other
inorgan
nanomateri
au
cu
ni
ti
zn
graphenebas
phototherm
well
coupl
deriv
potenti
candid
enhanc
restor
alreadi
exist
antibiot
new
substanc
combat
multidrugresist
mdr
problem
figur
nanoparticl
inde
potenti
broad
spectrum
antibiot
inhibit
wide
rang
mdr
bacteria
defi
antibiot
treatment
exampl
cuonanoparticl
exert
antibacteri
activ
membran
disrupt
ro
product
show
antibacteri
efficaci
alik
ag
zno
hand
effect
affect
bacteri
cell
along
two
pathway
bind
membran
disrupt
potenti
integr
induct
ro
product
henc
inhibit
growth
mssa
mrsa
mdr
pathogen
streptococcu
mutan
lactobacillu
klebsiella
pneumonia
e
coli
includ
esbl
produc
also
prevent
biofilm
format
figur
nanoshuttl
system
deliv
antibiot
precis
locat
releas
progress
control
manner
shuttl
system
system
use
nanoparticl
deliveri
control
releas
sever
antibiot
natur
product
nanoparticl
free
move
uninhibit
cell
increas
effici
antibiot
releas
insid
microorgan
increas
therapeut
index
reduc
overal
serum
concentr
result
deleteri
side
effect
decreas
addit
advantag
decreas
risk
creat
resist
commens
microorgan
applic
focus
treatment
osteomyel
skin
wound
aureu
e
coli
pseudomona
aeruginosa
infect
antimicrobi
nanomateri
current
use
investig
base
ag
magnetit
zno
nanotechnolog
also
make
great
progress
combat
infect
associ
medic
devic
relat
biofilm
format
implement
tailor
coat
system
system
base
coat
surfac
nanoparticl
inhibit
biofilm
format
studi
focus
pathogen
frequent
associ
nosocomi
infect
aureu
p
aeruginosa
acinetobact
baumani
k
pneumonia
figur
min
et
al
demonstr
applic
coat
degrad
multilay
prosthesi
coat
prosthesi
sequenti
deliv
antibiot
osteoinduct
growth
factor
coat
deliveri
system
enabl
erad
establish
biofilm
well
complet
rapid
bone
tissu
repair
around
implant
rat
induc
osteomyel
find
demonstr
potenti
layer
releas
strategi
milo
et
al
publish
novel
previous
unreport
applic
phrespons
polym
duallay
surfac
coat
urinari
cathet
provid
visual
earli
warn
proteu
mirabili
infect
subsequ
blockag
control
nanoparticl
keep
offer
promis
altern
design
effect
nextgener
therapeut
bacteri
viral
fungal
threat
perspect
develop
power
nanoantimicrobi
agent
multiplefunction
revolution
clinic
medicin
play
signific
role
allevi
diseas
burden
nanoparticlebas
antimicrobi
agent
use
ex
vivo
applic
steril
surfac
devic
prospect
topic
applic
wound
heal
nanoparticlesbas
system
figur
current
drug
deliveri
system
dd
usual
name
nanoantibiot
clinicallyapprov
human
use
variou
infecti
diseas
among
liposom
deliveri
system
grifol
sa
barcelona
spain
aradigm
corpor
hayward
ca
usa
inhal
liposom
dosag
form
ciprofloxacin
treatment
seriou
infecti
diseas
encount
cystic
fibrosi
cf
noncf
bronchiectasi
axenti
pharma
zurich
swizerland
base
technolog
insm
inc
monmouth
junction
nj
usa
undergo
phase
iii
clinic
trial
respect
inhal
liposom
tobramycin
amikacin
dosag
form
claim
treatment
p
aeruginosa
pulmonari
infect
cf
nanobiotechnolog
offer
multipl
solut
prevent
diagnosi
treatment
infecti
diseas
nanoparticl
design
increas
activ
vaccin
low
toxic
host
huge
number
nanoparticl
use
deliveri
stabil
bioactiv
drug
well
antimicrobi
molecul
ensur
control
releas
drug
due
specif
low
dimens
target
deliveri
control
releas
properti
low
cytotox
nanoact
system
could
lead
effici
less
invas
therapeut
outcom
contribut
develop
person
treatment
sever
infecti
diseas
superbug
era
nanotechnolog
offer
new
approach
allow
us
fight
resist
bacteria
nanobiomedicin
offer
new
tool
appli
prevent
detect
treatment
infecti
diseas
manag
decreas
comorbiditymort
ratio
cost
improv
lifestyl
qualiti
